“Academic Drug Discovery and the Integration of Genomic Insights”
Edward Holson, Ph.D. is the Director of Medicinal Chemistry at the Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard. In February 2008, Ed joined the medicinal chemistry group at the Stanley Center to design and implement strategies towards developing novel therapies in CNS related disorders including schizophrenia, bipolar and cognitive functional impairment. These strategies include key collaborations within the academic communities of MIT, Harvard and Massachusetts General Hospital.
Time: 2:00 PM – 3:00 PM
Place:
The Lieber Institute for Brain Development
Rangos Building
Main Conf. Room
Suite 300
855 N. Wolfe St.
Baltimore, MD 21205